198 related articles for article (PubMed ID: 35542324)
1. Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from
Lin CH; Kuo YH; Shih CC
RSC Adv; 2018 Jun; 8(37):20462-20476. PubMed ID: 35542324
[TBL] [Abstract][Full Text] [Related]
2. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic and Antihyperlipidemic Properties of a Triterpenoid Compound, Dehydroeburicoic Acid, from Antrodia camphorata in Vitro and in Streptozotocin-Induced Mice.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Nov; 63(46):10140-51. PubMed ID: 26503742
[TBL] [Abstract][Full Text] [Related]
4. Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from
Lin CH; Hsiao LW; Kuo YH; Shih CC
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31581697
[TBL] [Abstract][Full Text] [Related]
5. Dehydroeburicoic Acid from Antrodia camphorata Prevents the Diabetic and Dyslipidemic State via Modulation of Glucose Transporter 4, Peroxisome Proliferator-Activated Receptor α Expression and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.
Kuo YH; Lin CH; Shih CC
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271603
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic and antihyperlipidemic activities of
Huang SM; Lin CH; Chang WF; Shih CC
Food Nutr Res; 2023; 67():. PubMed ID: 37850072
[TBL] [Abstract][Full Text] [Related]
7. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
Kuo YH; Lin CH; Shih CC
J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice.
Lin CH; Wu JB; Jian JY; Shih CC
PLoS One; 2017; 12(3):e0173984. PubMed ID: 28333970
[TBL] [Abstract][Full Text] [Related]
9. Antcin K, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects via Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in Muscles.
Kuo YH; Lin CH; Shih CC; Yang CS
Evid Based Complement Alternat Med; 2016; 2016():4867092. PubMed ID: 27242912
[TBL] [Abstract][Full Text] [Related]
10. Validation of the Antidiabetic and Hypolipidemic Effects of Clitocybe nuda by Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin-Induced Mice.
Shih CC; Chen MH; Lin CH
Evid Based Complement Alternat Med; 2014; 2014():705636. PubMed ID: 24639883
[TBL] [Abstract][Full Text] [Related]
11. Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation.
Wu JB; Kuo YH; Lin CH; Ho HY; Shih CC
J Agric Food Chem; 2014 Nov; 62(44):10717-26. PubMed ID: 25317836
[TBL] [Abstract][Full Text] [Related]
12. Effects of Bofu-Tsusho-San on diabetes and hyperlipidemia associated with AMP-activated protein kinase and glucose transporter 4 in high-fat-fed mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2014 Nov; 15(11):20022-44. PubMed ID: 25375187
[TBL] [Abstract][Full Text] [Related]
13. (-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice.
Shih CC; Wu JB; Jian JY; Lin CH; Ho HY
Int J Mol Sci; 2015 Oct; 16(10):24983-5001. PubMed ID: 26492243
[TBL] [Abstract][Full Text] [Related]
14. Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production.
Kuo YH; Lin CH; Shih CC
Evid Based Complement Alternat Med; 2014; 2014():821569. PubMed ID: 25140189
[TBL] [Abstract][Full Text] [Related]
15. YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats.
Li F; Liu G; Xue P; Ren Z; Dai P; Niu W; Xin M
Evid Based Complement Alternat Med; 2021; 2021():5511019. PubMed ID: 34621322
[TBL] [Abstract][Full Text] [Related]
16. Antihyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats.
Chan P; Wong KL; Liu IM; Tzeng TF; Yang TL; Cheng JT
J Hypertens; 2003 Apr; 21(4):761-9. PubMed ID: 12658023
[TBL] [Abstract][Full Text] [Related]
17. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
18. Berberine Inhibits Gluconeogenesis in Skeletal Muscles and Adipose Tissues in Streptozotocin-induced Diabetic Rats via LKB1-AMPK-TORC2 Signaling Pathway.
Xu XH; Hu Q; Zhou LS; Xu LJ; Zou X; Lu FE; Yi P
Curr Med Sci; 2020 Jun; 40(3):530-538. PubMed ID: 32681256
[TBL] [Abstract][Full Text] [Related]
19. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
[TBL] [Abstract][Full Text] [Related]
20. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
